Based on the in vitro results in DLBCL from Kwanhian et al., it is reasonable to infer that the same mutation in FL also results in the upregulation of RAC1, which could play a role in FL tumorigenesis. Here, RAC1 is linked to diffuse large B-cell lymphoma.